Belgian Court orders AstraZeneca to deliver vaccine doses to the EU – Questions and Answers

This article is brought to you in association with the European Commission. Why did the European Commission start this Court proceeding and what did it intend to obtain? The company announced in January that it would not be in a position to deliver the number of doses laid down in the contract. The Commission and the […]

Statement by Commissioner Kyriakides on the review by the European Medicines Agency of the AstraZeneca COVID-19 vaccine

This article is brought to you in association with the European Commission. Following a  formal request by the European Commission, the European Medicines Agency has reviewed additional vaccination and epidemiological data submitted by Member States in relation to the AstraZeneca vaccine to give a more precise scientific opinion on the safety profile of the vaccine in […]

Statement following the European Medicines Agency review of the COVID-19 vaccine AstraZeneca

This article is brought to you in association with the European Commission. Following the European Medicines Agency’s safety committee’s review of the COVID-19 vaccine AstraZeneca at its extraordinary meeting of 18 March 2021, Stella Kyriakides, Commissioner for Health and Food Safety, made the following statement: “Security and trust in vaccines is key for vaccinations. The priority […]

Vaccines: contract between European Commission and AstraZeneca now published

This article is brought to you in association with the European Commission. Following the renewed request from the European Commission on 27 January 2021, pharmaceutical company AstraZeneca has agreed to publish the redacted contract signed between the two parties on 27 August 2020. The Commission welcomes the company’s commitment towards more transparency in its participation in […]

Is there a drug for every disease?

Pharmaceutical firms in Europe have an awkward relation with their customers. The truth is that their selling prices and product licencing are directly or indirectly controlled by the buyers, that is governments, or government control health insurance schemes, offering almost free health services to citizens. As everybody knows governments are not only able to influence […]

Why banks escape from competition rules but not pharmaceutical firms

Antitrust EU Commission services have an excellent record in identifying, monitoring, substantiating with facts and finally punishing cartels and dominant position abuses. This last week two concrete cases stand witnesses to that.Protecting consumers In the first case the European Court of Justice rejected an appeal against a General Court’s decision, which had upheld almost completely […]